Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study

Digestive Diseases and Sciences

Volumn 62, Issue 6, 2017, Pages 1571-1579

  Fumery, Mathurin ^a,b   Kohut, Mathieu ^c   Gower Rousseau, Corinne ^d,e   Duhamel, Alain ^f   Brazier, Franck ^a,b   Thelu, Francoise ^g   Nagorniewicz, Francis ^g   Lamarche, Francois ^h   Nguyen Khac, Eric ^a   Sabbagh, Charles ^a   Loreau, Julien ^a   Colombel, Jean Frederic ⁱ   Savoye, Guillaume ^j   Chatelain, Denis ^a   Dupas, Jean Louis ^a,b   Bartoli, E ^k   Bental, A ^k   Brazier, F ^k   Butel, J ^k   Capron Chivrac, D ^k   Coevoet, H ^k   Cohen, G ^k   Dadamessi, I ^k   Delcenserie, R ^k   Delgrange, T ^k   Descombes, P ^k   Dupas, J L ^k   Heyman, B ^k   Joly, J P ^k   Lagarde, M ^k   Laude, D ^k   Mancheron, H ^k   Nguyen Khac, E ^k   Papazian, A ^k   Pauwels, B ^k   Pauwels, M ^k   Prevost, J C ^k   Reix Branche, N ^k   Rudelli, A ^k   Sevenet, F ^k   Triplet, C ^k   Wantiez, M ^k   more..

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b EPIMAD registry   (France)

^c St Isabelle Clinic   (France)

^d UNIVERSITÉ DE LILLE   (France)

^e UNIV LILLE   (France)

^f Faculté de Médecine Pôle Recherché   (France)

^g Pathology Laboratory   (France)

^h Pathology Laboratory   (France)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j UNIVERSITÉ DE ROUEN   (France)

^k NONE

more..

Author keywords

Collagenous colitis; Incidence; Lymphocytic colitis; Microscopic colitis; Population based

Indexed keywords

BUDESONIDE; CORTICOSTEROID; ETANERCEPT; METHOTREXATE; PROTON PUMP INHIBITOR; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC DIARRHEA; CLINICAL FEATURE; COLLAGENOUS COLITIS; COLON BIOPSY; CROHN DISEASE; ENDOSCOPY; FEMALE; FRANCE; HUMAN; INCIDENCE; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; PATHOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; RHEUMATOID ARTHRITIS; RISK FACTOR; TREATMENT OUTCOME; ULCERATIVE COLITIS; VERY ELDERLY; ADOLESCENT; ANTAGONISTS AND INHIBITORS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, ULCERATIVE; COMORBIDITY; COMPLICATION; DIARRHEA; MIDDLE AGED; SEX DIFFERENCE; YOUNG ADULT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, ULCERATIVE; COMORBIDITY; CROHN DISEASE; DIARRHEA; FEMALE; FRANCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84988734607     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-016-4306-z     Document Type: Article

References (43)

1. Bohr J, Tysk C, Eriksson S, Järnerot G. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984–1993. Gut. 1995;37:394–397.
2. Bjørnbak C, Engel PJ, Nielsen PL, Munck LK. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther. 2011;34:1225–1234.
3. Thörn M, Sjöberg D, Ekbom A, et al. Microscopic colitis in Uppsala health region, a population-based prospective study 2005–2009. Scand J Gastroenterol. 2013;48:825–830.
4. Gentile NM, Khanna S, Loftus EV Jr, et al. The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study. Clin Gastroenterol Hepatol. 2014;12:838–842.
5. Stewart M, Andrews CN, Urbanski S, et al. The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther. 2011;33:1340–1349.
6. Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci. 2002;47:1122–1128.
7. Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998. Gut. 2004;53:346–350.
8. Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol. 2008;6:35–40.
9. Fernández-Bañares F, Salas A, Forné M, et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol. 1999;94:418–423.
10. Fernández-Bañares F, Salas A, Esteve M, et al. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study. Inflamm Bowel Dis. 2011;17:1015–1020.
11. Tong J, Zheng Q, Zhang C, et al. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:265–276.
12. Bonderup OK, Fenger-Grøn M, Wigh T, et al. Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases. Inflamm Bowel Dis. 2014;20:1702–1707.
13. Park T, Cave D, Marshall C. Microscopic colitis: A review of etiology, treatment and refractory disease. World J Gastroenterol. 2015;21:8804–8810.
14. Pardi DS, Loftus EV Jr, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County. Minnesota. Gut. 2007;56:504–508.
15. Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis—proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 2005;22:277–284.
16. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994;35:1433–1438.
17. Limsui D, Pardi DS, Smyrk TC, et al. Observer variability in the histologic diagnosis of microscopic colitis. Inflamm Bowel Dis. 2009;15:35–38.
18. Libbrecht L, Croes R, Ectors N, et al. Microscopic colitis with giant cells. Histopathology. 2002;40:335–338.
19. Fernández-Bañares F, Casalots J, Salas A, et al. Paucicellular lymphocytic colitis: is it a minor form of lymphocytic colitis? A clinical pathological and immunological study. Am J Gastroenterol. 2009;104:1189–1198.
20. Rubio CA, Lindholm J. Cryptal lymphocytic coloproctitis: a new phenotype of lymphocytic colitis? J Clin Pathol. 2002;55:138–140.
21. Yuan S, Reyes V, Bronner MP. Pseudomembranous collagenous colitis. Am J Surg Pathol. 2003;27:1375–1379.
22. Sandmeier D, Bouzourene H. A rare variant of microscopic colitis with granulomatous inflammation. Histopathology. 2005;47:644–645.
23. Macaigne G, Lahmek P, Locher C, et al. Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study. Am J Gastroenterol. 2014;109:1461–1470.
24. Lazenby AJ, Yardley JH, Giardiello FM, et al. Lymphocytic (“microscopic”) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol. 1989;20:18–28.
25. Barta Z, Mekkel G, Csípo I, et al. Microscopic colitis: a retrospective study of clinical presentation in 53 patients. World J Gastroenterol. 2005;11:1351–1355.
26. Jobse P, Flens MJ, Loffeld RJ. Collagenous colitis: description of a single centre series of 83 patients. Eur J Intern Med. 2009;20:499–502.
27. Katsinelos P, Katsos I, Patsiaoura K, et al. A new endoscopic appearance of collagenous colitis. Endoscopy. 1997;29:135.
28. Richieri JP, Bonneau HP, Cano N, et al. Collagenous colitis: an unusual endoscopic appearance. Gastrointest Endosc. 1993;39:192–194.
29. Pardi DS, Ramnath VR, Loftus EV Jr, et al. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol. 2002;97:2829–2833.
30. Pokorny CS, Kneale KL, Henderson CJ. Progression of collagenous colitis to ulcerative colitis. J Clin Gastroenterol. 200;32:435-8.
31. Münch A, Bohr J, Miehlke S, et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut. 2016;65:47–56.
32. Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol. 2009;104:235–241.
33. Miehlke S, Madisch A, Karimi D, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology. 2009;136:2092–2100.
34. Vigren L, Olesen M, Benoni C, Sjöberg K. An epidemiological study of collagenous colitis in southern Sweden from 2001-2010. World J Gastroenterol. 2012;18:2821–2826.
35. Wickbom A, Bohr J, Eriksson S, Udumyan R, Nyhlin N, Tysk C. Stable incidence of collagenous colitis and lymphocytic colitis in Örebro, Sweden, 1999-2008: a continuous epidemiologic study. Inflamm Bowel Dis. 2013;19:2387–2393.
36. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13:254–261.
37. Pinchbeck BR, Kirdeikis J, Thomson AB. Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol. 1988;10:505–515.
38. Tysk C, Jarnerot G. Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963–1987. Scand J Gastroenterol. 1992;27:945–950.
39. Lindberg E, Jornerot G. The incidence of Crohn’s disease is not decreasing in Sweden. Scand J Gastroenterol. 1991;26:495–500.
40. Brahme F, Lindstrom C, Wenckert A. Crohn’s disease in a defined population. An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmo, Sweden. Gastroenterology. 1975;69:342–351.
41. Stewenius J, Adnerhill I, Ekelund G, et al. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol. 1995;30:38–43.
42. Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100:350–358.
43. Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990–1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol. 2000;12:31–38.